Syndecan-1 Antigen, a Promising New Target for Triple-negative Breast Cancer Immuno-pet and Radioimmunotherapy. a Preclinical Study on Mda-mb-468 Xenograft Tumors
暂无分享,去创建一个
F. Kraeber-Bodéré | J. Barbet | D. Loussouarn | J. Wijdenes | A. Faivre-Chauvet | C. Rousseau | M. Chérel | S. Gouard | F. Davodeau | J. Gaschet | K. Bernardeau | A. Ruellan | C. Saï-Maurel